Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSTERIS plc

STERIS plc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
252.3 USD -1.82 ( 0.72%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1331955
Market Cap
20502.32M
P/E
25.71

Momentum Score

…

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
248.03
Low
253.44
High
52 Week Price Range
193.97
Low
267.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
254.12
Dividend Yield
1.18%
Revenue TTM
6037.50M
Revenue Per Share
61.61
Gross Profit TTM
2682.00M
Debt / Equity
0.29
ROE
11.39%
Net Debt
1647.50M
ROCE
11.55%
Diluted EPS TTM
8.18

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 1047.30M 796.21M 702.81M 157.35M 314.50M
Minority interest -2.80M -1.43M -1.84M 1.22M 1.02M
Net income 785.10M 614.64M 378.24M 107.03M 243.89M
Selling general administrative 1407.70M 1303.17M 1201.32M 1298.88M 1502.75M
Selling and marketing expenses - 19.95M 25.47M - -
Gross profit 2626.50M 2402.76M 2218.16M 2159.69M 2016.36M
Reconciled depreciation 486.50M 476.21M 565.24M 552.90M 553.10M
Ebit 1108.00M 882.47M 847.16M 268.19M -127.39M
Ebitda 1594.50M 1358.68M 1412.40M 1250.29M 425.71M
Depreciation and amortization 486.50M 476.21M 565.24M 982.10M 553.10M
Non operating income net other - - - -2.85M -
Operating income 1101.80M 866.64M 836.12M 268.19M 425.62M
Other operating expenses 4834.10M 4592.87M 4302.58M 4198.60M 4159.40M
Interest expense 60.70M 86.26M 144.35M 109.62M 89.59M
Tax provision 262.20M 184.65M 149.53M 51.53M 71.63M
Interest income 9.80M 8.40M 11.04M 110.84M 6.28M
Net interest income -50.90M -77.86M -133.31M -110.84M -83.31M
Extraordinary items - 4.52M -173.20M - -
Non recurring - - - 491.05M -
Income tax expense 262.20M 184.65M 149.53M 51.53M 71.63M
Total revenue 5935.90M 5459.52M 5138.70M 4957.84M 4585.06M
Total operating expenses 1524.70M 1536.12M 1382.04M 1400.46M 1590.70M
Cost of revenue 3309.40M 3056.75M 2920.54M 2798.15M 2568.70M
Total other income expense net -54.50M -70.43M -133.31M -601.89M -111.16M
Net income from continuing ops 785.10M 611.56M 553.28M 105.81M 242.87M
Net income applicable to common shares - 614.64M 378.24M 107.03M 243.89M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 10737.20M 10146.81M 11063.70M 10821.84M 11452.60M
Intangible assets 1620.00M 1854.39M 2119.28M 2955.78M 3328.54M
Other current assets 230.40M 203.77M 979.25M 179.28M 156.64M
Total liab 3540.00M 3531.05M 4748.35M 4734.67M 4907.96M
Total stockholder equity 7183.60M 6603.40M 6302.16M 6087.17M 6544.64M
Deferred long term liab - - - 617.54M -
Other current liab 592.40M 524.70M 478.13M 394.98M 406.35M
Common stock - 4420.41M 4543.18M 4486.38M 4742.92M
Capital stock 4280.90M 4420.41M 4543.18M 4486.38M 4742.92M
Retained earnings 3015.90M 2475.33M 2087.64M 1911.53M 1999.24M
Other liab - - - 693.67M 1040.26M
Good will 4194.80M 4095.68M 4070.71M 3879.22M 4404.34M
Other assets - 83.05M 0.00M 78.14M 70.66M
Cash 439.60M 171.70M 207.02M 208.36M 348.32M
Cash and equivalents - 171.70M 207.02M 208.36M 348.32M
Total current liabilities 1145.00M 1022.17M 931.13M 861.84M 922.22M
Current deferred revenue 59.10M 57.50M 70.46M 92.28M 110.79M
Net debt 1647.50M 2030.84M 3176.15M 2810.30M 2776.51M
Short term debt 154.70M 159.20M 117.18M 94.96M 179.35M
Short long term debt 118.90M 125.00M 85.94M 60.00M 142.88M
Short long term debt total 2087.10M 2202.54M 3383.17M 3018.66M 3124.83M
Other stockholder equity 4280.80M 6615.76M -328.66M 9.97M 12.28M
Property plant equipment - 2112.93M 1938.38M 1705.51M 1741.06M
Total current assets 2394.60M 2000.77M 2869.12M 2011.44M 1879.00M
Net tangible assets - - - 2197.98M -1217.25M
Net receivables 1092.80M 1043.96M 1008.32M 928.32M 799.04M
Long term debt 1812.90M 1918.70M 3120.16M 3018.66M 2945.48M
Inventory 631.80M 581.33M 674.53M 695.49M 575.00M
Accounts payable 338.80M 280.77M 251.72M 279.62M 225.74M
Noncontrolling interest in consolidated entity - - - 9.97M -
Accumulated other comprehensive income -113.10M -292.34M -328.66M -320.71M -209.81M
Common stock total equity - - - 4486.38M -
Retained earnings total equity - - - 1911.53M -
Non currrent assets other 211.40M 68.75M 66.20M 78.14M 70.66M
Non current assets total 8342.60M 8146.05M 8194.57M 8810.40M 9573.60M
Capital lease obligations 155.40M 158.84M 177.07M 195.45M 191.53M
Long term debt total - 1918.70M 3120.16M 3018.66M 2945.48M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments -134.00M 388.77M -887.36M -383.33M -666.56M
Change to liabilities - - - 31.29M 14.89M
Total cashflows from investing activities -512.50M 388.77M -887.36M -383.33M -666.56M
Net borrowings -122.00M -1164.43M 121.49M 150.66M 372.18M
Total cash from financing activities -568.20M -1572.36M -85.19M -498.72M 115.83M
Change to operating activities - - - -46.14M -148.82M
Net income 785.10M 616.07M 380.08M 105.81M 242.87M
Change in cash 267.90M -35.32M -1.34M -139.96M 127.79M
Begin period cash flow 171.70M 207.02M 208.36M 348.32M 220.53M
End period cash flow 439.60M 171.70M 207.02M 208.36M 348.32M
Total cash from operating activities 1341.40M 1148.09M 973.27M 756.95M 684.81M
Depreciation 486.50M 476.21M 565.24M 552.90M 553.10M
Other cashflows from investing activities 10.60M 9.20M 7.38M -21.36M -379.00M
Dividends paid 241.80M 219.88M 200.57M -183.50M -163.17M
Change to inventory -24.00M 73.07M -37.45M -123.92M -102.92M
Change to account receivables -25.10M -28.82M -128.07M -133.30M -51.97M
Sale purchase of stock -235.50M -211.32M -11.77M -308.56M -55.78M
Other cashflows from financing activities -1.80M 23.26M 5.66M -2.27M 1962.60M
Change to netincome - - - 340.90M 223.31M
Capital expenditures 369.00M 370.09M 360.33M 361.97M 287.56M
Change receivables - - - -133.30M -
Cash flows other operating - - - -16.72M -
Cash and cash equivalents changes - - - -125.10M -
Change in working capital 27.10M 66.51M -146.08M -250.02M -148.82M
Stock based compensation 61.70M 57.40M 56.53M 38.95M 57.66M
Other non cash items -2.10M 8.43M 248.91M 495.22M 86.62M
Free cash flow 972.40M 778.00M 612.95M 394.98M 397.25M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
STE
STERIS plc		 -1.82
0.72%		 252.30 25.71 19.61 3.40 2.89 3.71 13.65
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

5960 Heisley Road, Mentor, OH, United States, 44060

440 354 2600

https://www.steris.com

17937

Name Title Year Born
Mr. Daniel A. Carestio Pres, CEO & Director 1973
Mr. Michael J. Tokich Sr. VP & CFO 1969
Mr. John Adam Zangerle Sr. VP, Gen. Counsel & Sec. 1967
Mr. Walter M. Rosebrough Jr. CEO Emeritus & Sr. Advisor 1954
Mr. Cary L. Majors Sr. VP of Americas Commercial Operations 1975
Mr. Andrew Xilas Sr. VP & GM of Dental 1965
Ms. Karen L. Burton Chief Accounting Officer, VP & Controller 1968
Julie Winter VP of Investor Relations & Corp. Communications NA
Ms. Mary Clare Fraser VP & Chief HR Officer 1970
Ms. Julia K. Madsen Sr. VP of Life Sciences 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…